Literature DB >> 27506511

Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study.

Emanuel D Costa1, Josefina Priotti2, Silvina Orlandi3, Darío Leonardi2, María C Lamas2, Teresa G Nunes1, Hermínio P Diogo1, Claudio J Salomon4, M João Ferreira5.   

Abstract

The saturation solubility of PVP:PZQ physical mixtures (PMs) and solid dispersions (SDs) prepared from ethanol (E/E) or ethanol/water (E/W) by the solvent evaporation method at 1:1, 2:1 and 3:1 ratio (w/w) was determined. The presence of PVP improves the solubility of PZQ (0.31±0.01mg/mL). A maximum of 1.29±0.03mg/mL of PZQ in solution was achieved for the 3:1 SD (E/E). The amount of PZQ in solution depends on the amount of polymer and on the preparation method. Solid-state NMR (ssNMR) and DSC were used to understand this behavior. Results show that PMs are a mixture of crystalline PZQ with the polymer, while SDs show different degrees of drug amorphization depending on the solvent used. For E/W SDs, PZQ exists in amorphous and crystalline states, with no clear correlation between the amount of crystalline PZQ and the amount of PVP. For E/E SDs, formulations with a higher percentage of PZQ are amorphous with the components miscible in domains larger than 3nm ((1)H ssNMR relaxation measurements). Albeit its higher saturation solubility, the 3:1 E/E PVP:PZQ sample has a significant crystalline content, probably due to the water introduced by the polymer. High PVP content and small crystal size account for this result.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DSC; Pharmaceutical formulations; Poly(vinylpyrrolidone); Praziquantel; Praziquantel (PubChem CID: 4891); Solid-state NMR

Mesh:

Substances:

Year:  2016        PMID: 27506511     DOI: 10.1016/j.ijpharm.2016.08.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.

Authors:  Luciana Damacena Silva; Nayana Ferreira Lima; Eva Carolina Arrua; Claudio Javier Salomon; Marina Clare Vinaud
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel.

Authors:  Ana Borrego-Sánchez; Rita Sánchez-Espejo; Beatrice Albertini; Nadia Passerini; Pilar Cerezo; César Viseras; C Ignacio Sainz-Díaz
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

3.  Predicting process design spaces for spray drying amorphous solid dispersions.

Authors:  Stefanie Dohrn; Pranay Rawal; Christian Luebbert; Kristin Lehmkemper; Samuel O Kyeremateng; Matthias Degenhardt; Gabriele Sadowski
Journal:  Int J Pharm X       Date:  2021-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.